Perspectives - Page 23

Early-Stage Partnering For Broad Platform Companies

Compelling scientific innovation and record-breaking IPOs and financings have led to a resurgence in the appeal and valuations of broad platform biopharma companies...

On-Demand Webinar Mar 1, 2021

Accelerating Access to New Innovative Treatments: Lessons From COVID-19

Whitepaper Jan 29, 2021

How Are Medical Affairs Organizations Proving Their Value?

Whitepaper Jan 28, 2021

Novel Cell-Type Therapeutic Platforms in Oncology (Part II): A Cell by Any Other Name… Does Not Work the Same

On-Demand Webinar Jan 26, 2021

Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape – Part II

View Jan 13, 2021

The Population Situation – The Future of Payer Perspectives

Some large payers with sophisticated infrastructure can answer their own questions – by analyzing their own data and assessing their broad “population situation” within and across multiple disease states.

View Jan 4, 2021

Value-based Contracts — Big Talk, Big Deal, or Real Deal?

View Jan 4, 2021

Vaccine Hesitancy: Using Behavioral Science to Increase Public Acceptance of a COVID-19 Vaccine

View Nov 30, 2020

How the Latest NICE Methods Consultation Could Impact Your Evidence Generation Strategy

Whitepaper Nov 27, 2020

‘Excel cannot complete this task’: Drawing parallels between UK Test and Trace and health economic models

Whitepaper Oct 30, 2020

A Call to Action During Breast Cancer Awareness Month

One year and six months after the US Food and Drug Administration (FDA) heard from dozens of women reporting a variety of breast implant related ailments, the federal agency has issued guidelines for breast implant manufacturers to include a black box warning to implants filled with saline or silicone gel.

View Oct 27, 2020

Navigating the Assessment of CAR T-Cell Therapies: Stepping Back to Look Forwards

Whitepaper Oct 23, 2020

Medical Affairs Unscripted | Building a Comprehensive Data Generation Program with Julie Cahill, MD

Podcast Oct 20, 2020

COVID-19: The Impact on Clinical Trials and a Catalyst for Change

View Oct 14, 2020

What is the Role of Health Literacy in the Era of COVID?

View Oct 12, 2020

The UK Joining Project Orbis Post-Brexit May Mean Compressed Timelines and Less Data for Health Technology Assessment Submissions

On Monday last week, UK Health Secretary Matt Hancock announced to the House of Commons that the UK will be part of Project Orbis, joining Canada, the United States, Australia, Switzerland and Singapore.

View Oct 12, 2020